We are looking for children 2–17 years old to join a clinical research to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or Crohn’s disease (including associated symptoms such as recurrent diarrhea, abdominal cramps, cramps, chronic fatigue and/or liver disease), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
